Junfeng Li
Impact in
- Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Infectious Diseases top 5%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
Papers in
-
- Receptor Mechanisms and Signaling 8
- Advanced biosensing and bioanalysis techniques 7
- RNA modifications and cancer 7
- RNA Research and Splicing 6
- Hepatology 18
- Liver physiology and pathology 6
- Co-authors
- Yusen Zhou (11 shared papers)Yan Guo (6 shared papers)Shihui Sun (7 shared papers)Xue Chen (3 shared papers)Guangyu Zhao (6 shared papers)Lanying Du (6 shared papers)Shi Jiang (5 shared papers)Pan Xue (2 shared papers)
- Journals
- Frontiers in Pharmacology (4 papers)Scientific Reports (4 papers)Cardiovascular Diabetology (3 papers)International Journal of Molecular Sciences (3 papers)Medicine (3 papers)
- Partner nations
- ChinaUnited StatesEthiopia
In The Last Decade
Junfeng Li
213 papers receiving 3.4k citations
Peers
Comparison fields: 5 of 163
- Cancer Research 322
- Infectious Diseases 386
- Molecular Biology 1.2k
- Immunology 333
- Hepatology 118
Countries citing papers authored by Junfeng Li
This map shows the geographic impact of Junfeng Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junfeng Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junfeng Li more than expected).
Fields of papers citing papers by Junfeng Li
This network shows the impact of papers produced by Junfeng Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junfeng Li. The network helps show where Junfeng Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Junfeng Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 223 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 182 | |
| 2 | 2020 | 88 | |
| 3 | 2022 | 78 | |
| 4 | 2015 | 73 | |
| 5 | 2014 | 72 | |
| 6 | 2020 | 72 | |
| 7 | 2020 | 69 | |
| 8 | 2015 | 66 | |
| 9 | 2020 | 64 | |
| 10 | 2019 | 63 | |
| 11 | 2020 | 54 | |
| 12 | 2017 | 52 | |
| 13 | 2016 | 49 | |
| 14 | 2004 | 46 | |
| 15 | 2009 | 45 | |
| 16 | 2001 | 44 | |
| 17 | 2016 | 42 | |
| 18 | 2017 | 42 | |
| 19 | 2018 | 41 | |
| 20 | 2020 | 40 |
About Junfeng Li
Junfeng Li is a scholar working on Molecular Biology, Hepatology, Cancer Research, Immunology and Pharmacology, having authored 223 papers that have together received 3.4k indexed citations. Recurring topics across this work include Receptor Mechanisms and Signaling (8 papers), Advanced biosensing and bioanalysis techniques (7 papers), Liver Disease Diagnosis and Treatment (7 papers), Pancreatic function and diabetes (7 papers), RNA modifications and cancer (7 papers), RNA Research and Splicing (6 papers), interferon and immune responses (6 papers) and Liver physiology and pathology (6 papers). The work is most often cited by research in Cancer Research (322 citations), Infectious Diseases (386 citations), Molecular Biology (1.2k citations), Immunology (333 citations) and Hepatology (118 citations). Junfeng Li has collaborated with scholars based in China, United States and Ethiopia. Frequent co-authors include Yusen Zhou, Yan Guo, Shihui Sun, Xue Chen, Guangyu Zhao, Lanying Du, Shi Jiang, Pan Xue, Yuting Jiang and Yuehong Chen. Their work appears in journals such as Frontiers in Pharmacology, Scientific Reports, Cardiovascular Diabetology, International Journal of Molecular Sciences and Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.